Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information


EU orphan designation number: EU/3/13/1117   
Active ingredient: Ramiprilat
Indication: Treatment of Stargardt’s disease
Sponsor: Iris Pharma
Les Nertières, allée Hector Pintus, 06610 La Gaude, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/03/2013 Orphan designation EMA/OD/175/12 (2013)1611 of 12/03/2013